{"meta": {"project": "Research Gap Agent", "student": "Sreeram Vasanth (U2322909K)", "supervisor": "Asst Prof Aaron Smargon, NTU CBE", "domain": "nucleic acid delivery / LNP / mRNA therapeutics", "stage": "Stage 1 complete → Stage 2 started", "repo": "https://github.com/vasanthsreeram/fyp-research-gap-agent", "counts": {"papers": 15, "claims": 27, "evidence": 56, "gaps": 30, "topics": 5, "tests_passed": 23}, "run_id": "run_f2c2ec7db50c", "extractor_mode": "llm", "model_default": "gpt-4o-mini", "updated": "2026-07-29"}, "charts": {"claim_types": {"mechanism": 16, "theory": 11}, "gap_kinds": {"delivery_barrier": 7, "untested_claim": 1, "mechanism_unknown": 1, "theory_vs_experiment": 15, "other": 6}, "extractors": {"heuristic": 27}, "gap_score_bins": {"0–0.4": 0, "0.4–0.6": 5, "0.6–0.8": 25, "0.8–1.0": 0}, "pipeline_funnel": {"papers": 15, "claims": 27, "evidence": 56, "gaps": 30, "topics": 5}}, "papers": [{"id": "paper_3a4393fc4242", "title": "Lipid nanoparticles for mRNA delivery", "year": 2021, "authors": ["Hou X", "Zaks T", "Langer R", "Dong Y"], "source": "fixture", "doi": "10.1038/s41578-021-00358-0", "venue": "Nature Reviews Materials"}, {"id": "paper_6481ce95c4b1", "title": "Ionizable lipid nanoparticles for RNA delivery: design, mechanism, and applications", "year": 2017, "authors": ["Cullis PR", "Hope MJ"], "source": "fixture", "doi": "10.1080/17425247.2017.1264387", "venue": "Molecular Therapy"}, {"id": "paper_70137c159dec", "title": "Combinatorial design of ionizable lipids for lipid nanoparticle delivery of mRNA", "year": 2022, "authors": ["Smith BJ", "McGuigan A", "Crawford L", "Ernst R"], "source": "fixture", "doi": "10.1021/acs.nanolett.2c01542", "venue": "Nano Letters"}, {"id": "paper_fa5bdf6c0470", "title": "Endosomal escape of lipid nanoparticles: a mechanistic investigation", "year": 2020, "authors": ["Patel S", "Ashwanikumar N", "Robinson E", "DuRoss A"], "source": "fixture", "doi": "10.1021/acs.nanolett.0c02526", "venue": "Nano Letters"}, {"id": "paper_a86d9c89919a", "title": "Extrahepatic targeting of lipid nanoparticles in vivo", "year": 2021, "authors": ["Cheng Q", "Wei T", "Farbiak L", "Johnson LT"], "source": "fixture", "doi": "10.1038/s41565-021-00902-5", "venue": "Nature Nanotechnology"}, {"id": "paper_54f36a919f2b", "title": "CRISPR-Cas9 lipid nanoparticle systems for in vivo gene editing", "year": 2018, "authors": ["Finn JD", "Smith AR", "Patel MC", "Shaw L"], "source": "fixture", "doi": "10.1016/j.celrep.2018.02.025", "venue": "Cell Reports"}, {"id": "paper_93c3ce4f700f", "title": "Structure-activity relationships of ionizable lipids for lipid nanoparticle delivery", "year": 2020, "authors": ["Hajj KA", "Ball RL", "Deluty SB", "Singh SR"], "source": "fixture", "doi": "10.1073/pnas.1911276116", "venue": "PNAS"}, {"id": "paper_8f84d6292278", "title": "Biodistribution and pharmacokinetics of lipid nanoparticle-formulated mRNA", "year": 2018, "authors": ["Sedic M", "Senn JJ", "Lynn A", "Laska M"], "source": "fixture", "doi": "10.1016/j.ymthe.2018.05.012", "venue": "Molecular Therapy"}, {"id": "paper_a83828e7d71b", "title": "Small interfering RNA delivery via lipid nanoparticles for liver target engagement", "year": 2018, "authors": ["Adams D", "Gonzalez-Duarte A", "O'Riordan WD", "Yang CC"], "source": "fixture", "doi": "10.1056/NEJMoa1716153", "venue": "New England Journal of Medicine"}, {"id": "paper_b5b91c14e719", "title": "mRNA vaccines against COVID-19: a perspective on LNP formulation design", "year": 2020, "authors": ["Pardi N", "Hogan MJ", "Porter FW", "Weissman D"], "source": "fixture", "doi": "10.1038/s41573-020-0073-2", "venue": "Nature Reviews Drug Discovery"}, {"id": "paper_b0ee8bd9e515", "title": "Nucleoside-modified mRNA-LNP therapeutics beyond vaccines: protein replacement and gene editing", "year": 2021, "authors": ["Richter M", "Siddiqui A", "Bardelli M", "Hackett CJ"], "source": "fixture", "doi": "10.1016/j.jconrel.2021.03.035", "venue": "Journal of Controlled Release"}, {"id": "paper_5fdcc326efaa", "title": "Advances in lipid nanoparticle delivery of nucleic acids and beyond", "year": 2021, "authors": ["Kulkarni JA", "Cullis PR", "van der Meel R"], "source": "fixture", "doi": "10.1038/s41573-021-00234-2", "venue": "Nature Reviews Drug Discovery"}, {"id": "paper_5c89ff1de470", "title": "Rapidly adaptable nanoparticle platforms for mRNA delivery to the lung", "year": 2021, "authors": ["Dong Y", "Love KT", "Dorkin JR", "Sirirungruang S"], "source": "fixture", "doi": "10.1073/pnas.2106632118", "venue": "PNAS"}, {"id": "paper_77a24f85f5ef", "title": "Lipid nanoparticle chemistry: from RNA delivery to the next generation of therapeutics", "year": 2019, "authors": ["Whitehead KA", "Dorkin JR", "Vegas AJ", "Chang PH"], "source": "fixture", "doi": "10.1038/s41578-019-0132-7", "venue": "Nature Reviews Materials"}, {"id": "paper_3b09ea60f1b3", "title": "The endosomal escape of lipid nanoparticles: mechanisms and strategies for improvement", "year": 2021, "authors": ["Vermeulen LMP", "De Smedt SC", "Remaut K", "Braeckmans K"], "source": "fixture", "doi": "10.1021/acs.accounts.1c00236", "venue": "Accounts of Chemical Research"}], "claims": [{"id": "claim_979467ccd5c6", "paper_id": "paper_3a4393fc4242", "paper_title": "Lipid nanoparticles for mRNA delivery", "claim_type": "mechanism", "text": "The ionizable lipid is the key determinant of potency, facilitating mRNA encapsulation and endosomal escape.", "confidence": 0.55, "tags": ["mrna", "endosomal_escape"], "extractor": "heuristic"}, {"id": "claim_bbccbfbfad21", "paper_id": "paper_3a4393fc4242", "paper_title": "Lipid nanoparticles for mRNA delivery", "claim_type": "theory", "text": "Here, we review the design principles of LNPs, their structure-activity relationships, and emerging strategies for tissue-specific delivery.", "confidence": 0.55, "tags": ["targeting"], "extractor": "heuristic"}, {"id": "claim_dd1a70a67798", "paper_id": "paper_3a4393fc4242", "paper_title": "Lipid nanoparticles for mRNA delivery", "claim_type": "mechanism", "text": "We identify several key gaps: the exact mechanism of endosomal escape remains controversial, extrahepatic targeting strategies have limited success in vivo, and the relationship between lipid pKa and in vivo efficacy is incompletely understood.", "confidence": 0.55, "tags": ["endosomal_escape", "targeting", "pka"], "extractor": "heuristic"}, {"id": "claim_d2177fda2791", "paper_id": "paper_6481ce95c4b1", "paper_title": "Ionizable lipid nanoparticles for RNA delivery: design, mechanism, and applications", "claim_type": "mechanism", "text": "Ionizable lipid nanoparticles for RNA delivery: design, mechanism, and applications  Ionizable lipids are the central functional component of lipid nanoparticles (LNPs) for RNA delivery.", "confidence": 0.55, "tags": [], "extractor": "heuristic"}, {"id": "claim_8bf5da551d2e", "paper_id": "paper_6481ce95c4b1", "paper_title": "Ionizable lipid nanoparticles for RNA delivery: design, mechanism, and applications", "claim_type": "theory", "text": "Key structure-activity relationships include the influence of tail length, unsaturation, and headgroup pKa on delivery efficiency.", "confidence": 0.55, "tags": ["pka"], "extractor": "heuristic"}, {"id": "claim_35a19836f531", "paper_id": "paper_6481ce95c4b1", "paper_title": "Ionizable lipid nanoparticles for RNA delivery: design, mechanism, and applications", "claim_type": "theory", "text": "The pKa of ionizable lipids correlates with in vivo potency, with an optimal pKa around 6.2-6.5 for hepatocyte delivery.", "confidence": 0.55, "tags": ["pka"], "extractor": "heuristic"}, {"id": "claim_697dd41c3b8f", "paper_id": "paper_6481ce95c4b1", "paper_title": "Ionizable lipid nanoparticles for RNA delivery: design, mechanism, and applications", "claim_type": "mechanism", "text": "However, mechanistic understanding of how ionizable lipids facilitate endosomal escape is still evolving.", "confidence": 0.55, "tags": ["endosomal_escape"], "extractor": "heuristic"}, {"id": "claim_7f58ff9de04f", "paper_id": "paper_6481ce95c4b1", "paper_title": "Ionizable lipid nanoparticles for RNA delivery: design, mechanism, and applications", "claim_type": "mechanism", "text": "Current evidence suggests that ionizable lipids disrupt the endosomal membrane through a flip-flop mechanism involving protonation-deprotonation cycles, but direct experimental evidence for this model remains limited.", "confidence": 0.55, "tags": ["endosomal_escape"], "extractor": "heuristic"}, {"id": "claim_c1289c3bfcb9", "paper_id": "paper_70137c159dec", "paper_title": "Combinatorial design of ionizable lipids for lipid nanoparticle delivery of mRNA", "claim_type": "theory", "text": "However, translation to extrahepatic tissues was not achieved, and the precise relationship between lipid structure and intracellular trafficking remains poorly understood.", "confidence": 0.55, "tags": ["targeting"], "extractor": "heuristic"}, {"id": "claim_11c6d9413092", "paper_id": "paper_fa5bdf6c0470", "paper_title": "Endosomal escape of lipid nanoparticles: a mechanistic investigation", "claim_type": "mechanism", "text": "Endosomal escape of lipid nanoparticles: a mechanistic investigation  The mechanism by which lipid nanoparticles (LNPs) escape the endosome is not fully understood.", "confidence": 0.55, "tags": ["endosomal_escape"], "extractor": "heuristic"}, {"id": "claim_99bdbbb525a8", "paper_id": "paper_fa5bdf6c0470", "paper_title": "Endosomal escape of lipid nanoparticles: a mechanistic investigation", "claim_type": "mechanism", "text": "We found that less than 5% of internalized mRNA reached the cytosol, indicating that endosomal escape is a major bottleneck.", "confidence": 0.55, "tags": ["mrna", "endosomal_escape"], "extractor": "heuristic"}, {"id": "claim_279203a0cb08", "paper_id": "paper_fa5bdf6c0470", "paper_title": "Endosomal escape of lipid nanoparticles: a mechanistic investigation", "claim_type": "mechanism", "text": "Ionizable lipids promoted membrane destabilization through a pH-dependent phase transition from lamellar to inverted hexagonal structures.", "confidence": 0.55, "tags": [], "extractor": "heuristic"}, {"id": "claim_4fbf813b5387", "paper_id": "paper_fa5bdf6c0470", "paper_title": "Endosomal escape of lipid nanoparticles: a mechanistic investigation", "claim_type": "mechanism", "text": "These findings suggest that endosomal escape efficiency must be improved at least 10-fold for LNP-based therapeutics to achieve their full potential.", "confidence": 0.4, "tags": ["lnp", "endosomal_escape"], "extractor": "heuristic"}, {"id": "claim_3dca6f81e23f", "paper_id": "paper_a86d9c89919a", "paper_title": "Extrahepatic targeting of lipid nanoparticles in vivo", "claim_type": "theory", "text": "A major barrier is the rapid formation of a protein corona on LNPs after injection, which masks targeting ligands and redirects particles to the liver.", "confidence": 0.4, "tags": ["corona"], "extractor": "heuristic"}, {"id": "claim_cb9ab4e64527", "paper_id": "paper_54f36a919f2b", "paper_title": "CRISPR-Cas9 lipid nanoparticle systems for in vivo gene editing", "claim_type": "theory", "text": "High-performance LNPs with optimized ionizable lipid MC3 achieved the highest editing in hepatocytes, but extrahepatic editing remains elusive.", "confidence": 0.4, "tags": ["targeting"], "extractor": "heuristic"}, {"id": "claim_60973cd15351", "paper_id": "paper_93c3ce4f700f", "paper_title": "Structure-activity relationships of ionizable lipids for lipid nanoparticle delivery", "claim_type": "theory", "text": "Structure-activity relationships of ionizable lipids for lipid nanoparticle delivery  We synthesized and evaluated 100+ ionizable lipidoids to understand structure-activity relationships (SAR) for mRNA delivery.", "confidence": 0.55, "tags": ["lnp", "mrna"], "extractor": "heuristic"}, {"id": "claim_9ba7cc80ccf3", "paper_id": "paper_93c3ce4f700f", "paper_title": "Structure-activity relationships of ionizable lipids for lipid nanoparticle delivery", "claim_type": "theory", "text": "Key findings: (1) lipid pKa between 6.0-6.8 is critical for in vivo potency, (2) unsaturated tails (C18:1, C18:2) outperform saturated tails, (3) ester linkages improve biodegradability without sacrificing activity, (4) tail length of C12-C16 provides optimal delivery.", "confidence": 0.4, "tags": ["pka"], "extractor": "heuristic"}, {"id": "claim_92fc9fdfdbb7", "paper_id": "paper_93c3ce4f700f", "paper_title": "Structure-activity relationships of ionizable lipids for lipid nanoparticle delivery", "claim_type": "theory", "text": "However, the same SAR rules do not apply across different administration routes (IV vs IM vs SC).", "confidence": 0.55, "tags": [], "extractor": "heuristic"}, {"id": "claim_c81b88a20828", "paper_id": "paper_93c3ce4f700f", "paper_title": "Structure-activity relationships of ionizable lipids for lipid nanoparticle delivery", "claim_type": "mechanism", "text": "Important gaps remain: the role of lipid shape in membrane curvature induction during endosomal escape is poorly characterized, and most SAR studies have been limited to a small number of cell types.", "confidence": 0.55, "tags": ["endosomal_escape"], "extractor": "heuristic"}, {"id": "claim_42a11d281a31", "paper_id": "paper_8f84d6292278", "paper_title": "Biodistribution and pharmacokinetics of lipid nanoparticle-formulated mRNA", "claim_type": "mechanism", "text": "Surprisingly, despite rapid hepatic uptake, only 2-5% of internalized mRNA was translated into protein, suggesting that LNP unpackaging and endosomal escape within hepatocytes is inefficient.", "confidence": 0.4, "tags": ["lnp", "mrna", "endosomal_escape"], "extractor": "heuristic"}, {"id": "claim_d87ec8e7b1d8", "paper_id": "paper_a83828e7d71b", "paper_title": "Small interfering RNA delivery via lipid nanoparticles for liver target engagement", "claim_type": "mechanism", "text": "Despite this success, several challenges remain: (1) extrahepatic delivery has not been clinically achieved, (2) LNP-mediated siRNA delivery requires relatively high doses (0.3 mg/kg), (3) the mechanism of intracellular release remains incompletely understood, and (4) immunogenicity limits repeat dosing.", "confidence": 0.55, "tags": ["lnp", "targeting"], "extractor": "heuristic"}, {"id": "claim_2d918c935d8c", "paper_id": "paper_b5b91c14e719", "paper_title": "mRNA vaccines against COVID-19: a perspective on LNP formulation design", "claim_type": "theory", "text": "Key gaps include: (1) mechanisms of LNP-induced inflammation remain poorly understood, (2) the contribution of specific lipid components to immune activation versus delivery efficiency is unclear, and (3) developing thermostable formulations that eliminate cold chain requirements remains a significant engineering challenge.", "confidence": 0.55, "tags": ["lnp"], "extractor": "heuristic"}, {"id": "claim_ddd854539c38", "paper_id": "paper_b0ee8bd9e515", "paper_title": "Nucleoside-modified mRNA-LNP therapeutics beyond vaccines: protein replacement and gene editing", "claim_type": "theory", "text": "Current LNPs are also less efficient at transducing primary cells compared to established cell lines, and the relationship between LNP composition and protein corona formation in different disease states is not understood.", "confidence": 0.4, "tags": ["lnp", "corona"], "extractor": "heuristic"}, {"id": "claim_355361545bdd", "paper_id": "paper_5fdcc326efaa", "paper_title": "Advances in lipid nanoparticle delivery of nucleic acids and beyond", "claim_type": "mechanism", "text": "We examine current understanding of LNP-cell interactions: cellular uptake (clathrin- and caveolae-mediated endocytosis), endosomal trafficking, and the poorly characterized mechanism of endosomal escape.", "confidence": 0.55, "tags": ["lnp", "endosomal_escape"], "extractor": "heuristic"}, {"id": "claim_661925345574", "paper_id": "paper_77a24f85f5ef", "paper_title": "Lipid nanoparticle chemistry: from RNA delivery to the next generation of therapeutics", "claim_type": "mechanism", "text": "Despite extensive SAR studies, fundamental questions remain: the precise molecular requirements for efficient endosomal escape are unknown, the role of lipid metabolism in nanoparticle clearance is underexplored, and predictive models for immunogenicity based on lipid structure have not been developed.", "confidence": 0.55, "tags": ["endosomal_escape"], "extractor": "heuristic"}, {"id": "claim_4a20fb1fa41d", "paper_id": "paper_3b09ea60f1b3", "paper_title": "The endosomal escape of lipid nanoparticles: mechanisms and strategies for improvement", "claim_type": "mechanism", "text": "The endosomal escape of lipid nanoparticles: mechanisms and strategies for improvement  Endosomal escape is the most critical bottleneck for lipid nanoparticle (LNP)-mediated nucleic acid delivery.", "confidence": 0.4, "tags": ["lnp", "endosomal_escape"], "extractor": "heuristic"}, {"id": "claim_45da4ae3a555", "paper_id": "paper_3b09ea60f1b3", "paper_title": "The endosomal escape of lipid nanoparticles: mechanisms and strategies for improvement", "claim_type": "mechanism", "text": "However, improvements in endosomal escape often correlate with increased toxicity, suggesting that potent escape and biocompatibility may require decoupling through novel chemical approaches.", "confidence": 0.55, "tags": ["endosomal_escape"], "extractor": "heuristic"}], "gaps": [{"id": "gap_9f9225cbc5d9", "kind": "delivery_barrier", "title": "Limitation: Extrahepatic targeting of lipid nanoparticles in vivo  Clinical use of lipid nan", "description": "Acknowledged limitation: \"Extrahepatic targeting of lipid nanoparticles in vivo  Clinical use of lipid nanoparticles (LNPs) is limited by their predominant accumulation in the liver after systemic administration.\" [Extrahepatic targeting of lipid nanoparticles in vivo]", "claim_ids": [], "evidence_ids": ["evid_81f812a56005"], "paper_ids": ["paper_a86d9c89919a"], "magnitude": 0.95, "novelty": 0.7, "testability": 0.7, "impact": 0.75, "overall": 0.77, "domain_tags": ["lnp", "targeting"], "rationale": "Unmatched author-stated limitation — candidate open problem.", "paper_titles": ["Extrahepatic targeting of lipid nanoparticles in vivo"]}, {"id": "gap_80d59228631f", "kind": "delivery_barrier", "title": "Limitation: These findings underscore the need for fundamental advances in understanding nan", "description": "Acknowledged limitation: \"These findings underscore the need for fundamental advances in understanding nano-bio interactions to achieve extrahepatic targeting.\" [Extrahepatic targeting of lipid nanoparticles in vivo]", "claim_ids": [], "evidence_ids": ["evid_04b9d6435a2d"], "paper_ids": ["paper_a86d9c89919a"], "magnitude": 0.95, "novelty": 0.7, "testability": 0.7, "impact": 0.57, "overall": 0.73, "domain_tags": ["targeting"], "rationale": "Unmatched author-stated limitation — candidate open problem.", "paper_titles": ["Extrahepatic targeting of lipid nanoparticles in vivo"]}, {"id": "gap_c25453bc60dc", "kind": "delivery_barrier", "title": "Limitation: We observed that less than 2% of LNP-encapsulated cargo reaches the cytosol, sug", "description": "Acknowledged limitation: \"We observed that less than 2% of LNP-encapsulated cargo reaches the cytosol, suggesting endosomal entrapment is the dominant barrier.\" [The endosomal escape of lipid nanoparticles: mechanisms and strategies for impro]", "claim_ids": [], "evidence_ids": ["evid_807ca8c720dc"], "paper_ids": ["paper_3b09ea60f1b3"], "magnitude": 0.95, "novelty": 0.7, "testability": 0.7, "impact": 0.55, "overall": 0.72, "domain_tags": ["lnp", "endosomal_escape"], "rationale": "Unmatched author-stated limitation — candidate open problem.", "paper_titles": ["The endosomal escape of lipid nanoparticles: mechanisms and strategies for improvement"]}, {"id": "gap_61529d4a08b6", "kind": "delivery_barrier", "title": "Limitation: Major unresolved challenges include achieving efficient delivery to non-hepatic ", "description": "Acknowledged limitation: \"Major unresolved challenges include achieving efficient delivery to non-hepatic tissues, overcoming biological barriers such as the mucus and blood-brain barriers, and reducing immunogenicity.\" [Advances in lipid nanoparticle delivery of nucleic acids and beyond]", "claim_ids": [], "evidence_ids": ["evid_4e0a330a6d79"], "paper_ids": ["paper_5fdcc326efaa"], "magnitude": 0.95, "novelty": 0.6, "testability": 0.7, "impact": 0.57, "overall": 0.7, "domain_tags": ["immunogenicity"], "rationale": "Unmatched author-stated limitation — candidate open problem.", "paper_titles": ["Advances in lipid nanoparticle delivery of nucleic acids and beyond"]}, {"id": "gap_19145e5736f3", "kind": "delivery_barrier", "title": "Limitation: However, delivery efficiency decreased by 80% when scaling from mice to rabbits,", "description": "Acknowledged limitation: \"However, delivery efficiency decreased by 80% when scaling from mice to rabbits, and repeat administration resulted in diminished returns due to innate immune activation.\" [Rapidly adaptable nanoparticle platforms for mRNA delivery to the lung]", "claim_ids": [], "evidence_ids": ["evid_032115c275fb"], "paper_ids": ["paper_5c89ff1de470"], "magnitude": 0.95, "novelty": 0.6, "testability": 0.7, "impact": 0.57, "overall": 0.7, "domain_tags": ["delivery_efficiency", "immunogenicity"], "rationale": "Unmatched author-stated limitation — candidate open problem.", "paper_titles": ["Rapidly adaptable nanoparticle platforms for mRNA delivery to the lung"]}, {"id": "gap_254c02bd1d30", "kind": "untested_claim", "title": "Untested: Despite extensive SAR studies, fundamental questions remain: the precise molecul", "description": "Claim without matching experimental evidence: \"Despite extensive SAR studies, fundamental questions remain: the precise molecular requirements for efficient endosomal escape are unknown, the role o\" [Lipid nanoparticle chemistry: from RNA delivery to the next generation of therap]", "claim_ids": ["claim_661925345574"], "evidence_ids": [], "paper_ids": ["paper_77a24f85f5ef"], "magnitude": 0.82, "novelty": 0.65, "testability": 0.72, "impact": 0.55, "overall": 0.69, "domain_tags": ["endosomal_escape", "pks", "immunogenicity"], "rationale": "Claim confidence 0.55, best evidence sim 0.00 (embedding). Claim type=mechanism, kind=untested_claim.", "paper_titles": ["Lipid nanoparticle chemistry: from RNA delivery to the next generation of therapeutics"]}, {"id": "gap_4a4077689510", "kind": "mechanism_unknown", "title": "Mechanism gap: Important gaps remain: the role of lipid shape in membrane curvature induction d", "description": "Mechanism claim lacks strong experimental support: \"Important gaps remain: the role of lipid shape in membrane curvature induction during endosomal escape is poorly charact\" [Structure-activity relationships of ionizable lipids for lipid nanoparticle deli]", "claim_ids": ["claim_c81b88a20828"], "evidence_ids": ["evid_cf8a4f686c96"], "paper_ids": ["paper_93c3ce4f700f"], "magnitude": 0.62, "novelty": 0.8, "testability": 0.55, "impact": 0.75, "overall": 0.68, "domain_tags": ["endosomal_escape"], "rationale": "Claim confidence 0.55, best evidence sim 0.38 (embedding). Claim type=mechanism, kind=mechanism_unknown.", "paper_titles": ["Structure-activity relationships of ionizable lipids for lipid nanoparticle delivery"]}, {"id": "gap_9a4ca6c6cd19", "kind": "delivery_barrier", "title": "Limitation: However, no formulation achieved significant targeting to muscle, heart, or brai", "description": "Acknowledged limitation: \"However, no formulation achieved significant targeting to muscle, heart, or brain.\" [Extrahepatic targeting of lipid nanoparticles in vivo]", "claim_ids": [], "evidence_ids": ["evid_b96676174ccc"], "paper_ids": ["paper_a86d9c89919a"], "magnitude": 0.95, "novelty": 0.6, "testability": 0.7, "impact": 0.45, "overall": 0.68, "domain_tags": [], "rationale": "Unmatched author-stated limitation — candidate open problem.", "paper_titles": ["Extrahepatic targeting of lipid nanoparticles in vivo"]}, {"id": "gap_4ece52c7cc9e", "kind": "delivery_barrier", "title": "Limitation: A key limitation is the lack of understanding of the biophysical interactions be", "description": "Acknowledged limitation: \"A key limitation is the lack of understanding of the biophysical interactions between LNPs and the mucus barrier.\" [Rapidly adaptable nanoparticle platforms for mRNA delivery to the lung]", "claim_ids": [], "evidence_ids": ["evid_0617a0fb72c6"], "paper_ids": ["paper_5c89ff1de470"], "magnitude": 0.95, "novelty": 0.6, "testability": 0.7, "impact": 0.45, "overall": 0.68, "domain_tags": ["lnp"], "rationale": "Unmatched author-stated limitation — candidate open problem.", "paper_titles": ["Rapidly adaptable nanoparticle platforms for mRNA delivery to the lung"]}, {"id": "gap_76449f85e804", "kind": "theory_vs_experiment", "title": "Gap: Ionizable lipids promoted membrane destabilization thro vs Endosomal escape of lipid nanoparticles: a mechanistic ", "description": "Claim vs limitation: \"Ionizable lipids promoted membrane destabilization through a pH-dependent phase transition from lame\" vs \"Endosomal escape of lipid nanoparticles: a mechanistic investigation  The mechanism by which lipid n\" [Endosomal escape of lipid nanoparticles: a mechanistic investigation]", "claim_ids": ["claim_279203a0cb08"], "evidence_ids": ["evid_307901423b96"], "paper_ids": ["paper_fa5bdf6c0470"], "magnitude": 0.77, "novelty": 0.65, "testability": 0.65, "impact": 0.55, "overall": 0.66, "domain_tags": ["lnp", "endosomal_escape"], "rationale": "Claim confidence 0.55, best evidence sim 0.44 (embedding). Claim type=mechanism, kind=theory_vs_experiment.", "paper_titles": ["Endosomal escape of lipid nanoparticles: a mechanistic investigation"]}, {"id": "gap_4f73406d9b80", "kind": "theory_vs_experiment", "title": "Gap: We identify several key gaps: the exact mechanism of en vs We identify several key gaps: the exact mechanism of en", "description": "Claim vs limitation: \"We identify several key gaps: the exact mechanism of endosomal escape remains controversial, extrahe\" vs \"We identify several key gaps: the exact mechanism of endosomal escape remains controversial, extrahe\" [Lipid nanoparticles for mRNA delivery]", "claim_ids": ["claim_dd1a70a67798"], "evidence_ids": ["evid_85bee00f4154"], "paper_ids": ["paper_3a4393fc4242"], "magnitude": 0.55, "novelty": 0.65, "testability": 0.65, "impact": 0.75, "overall": 0.65, "domain_tags": ["endosomal_escape", "targeting"], "rationale": "Claim confidence 0.55, best evidence sim 1.00 (embedding). Claim type=mechanism, kind=theory_vs_experiment.", "paper_titles": ["Lipid nanoparticles for mRNA delivery"]}, {"id": "gap_d147c9255c8a", "kind": "theory_vs_experiment", "title": "Gap: The endosomal escape of lipid nanoparticles: mechanisms vs The endosomal escape of lipid nanoparticles: mechanisms", "description": "Claim vs limitation: \"The endosomal escape of lipid nanoparticles: mechanisms and strategies for improvement  Endosomal es\" vs \"The endosomal escape of lipid nanoparticles: mechanisms and strategies for improvement  Endosomal es\" [The endosomal escape of lipid nanoparticles: mechanisms and strategies for impro]", "claim_ids": ["claim_4a20fb1fa41d"], "evidence_ids": ["evid_872321de2ac2"], "paper_ids": ["paper_3b09ea60f1b3"], "magnitude": 0.55, "novelty": 0.65, "testability": 0.65, "impact": 0.67, "overall": 0.63, "domain_tags": ["lnp", "endosomal_escape"], "rationale": "Claim confidence 0.40, best evidence sim 1.00 (embedding). Claim type=mechanism, kind=theory_vs_experiment.", "paper_titles": ["The endosomal escape of lipid nanoparticles: mechanisms and strategies for improvement"]}, {"id": "gap_3079431e631c", "kind": "theory_vs_experiment", "title": "Gap: Current evidence suggests that ionizable lipids disrupt vs However, mechanistic understanding of how ionizable lip", "description": "Claim vs limitation: \"Current evidence suggests that ionizable lipids disrupt the endosomal membrane through a flip-flop m\" vs \"However, mechanistic understanding of how ionizable lipids facilitate endosomal escape is still evol\" [Ionizable lipid nanoparticles for RNA delivery: design, mechanism, and applicati]", "claim_ids": ["claim_7f58ff9de04f"], "evidence_ids": ["evid_773844c79a15"], "paper_ids": ["paper_6481ce95c4b1"], "magnitude": 0.64, "novelty": 0.65, "testability": 0.65, "impact": 0.55, "overall": 0.62, "domain_tags": ["lnp", "endosomal_escape"], "rationale": "Claim confidence 0.55, best evidence sim 0.78 (embedding). Claim type=mechanism, kind=theory_vs_experiment.", "paper_titles": ["Ionizable lipid nanoparticles for RNA delivery: design, mechanism, and applications"]}, {"id": "gap_0640396a297e", "kind": "theory_vs_experiment", "title": "Gap: However, translation to extrahepatic tissues was not ac vs However, translation to extrahepatic tissues was not ac", "description": "Claim vs limitation: \"However, translation to extrahepatic tissues was not achieved, and the precise relationship between \" vs \"However, translation to extrahepatic tissues was not achieved, and the precise relationship between \" [Combinatorial design of ionizable lipids for lipid nanoparticle delivery of mRNA]", "claim_ids": ["claim_c1289c3bfcb9"], "evidence_ids": ["evid_f3aa6a555fb6"], "paper_ids": ["paper_70137c159dec"], "magnitude": 0.55, "novelty": 0.6, "testability": 0.65, "impact": 0.67, "overall": 0.62, "domain_tags": ["endosomal_escape", "targeting"], "rationale": "Claim confidence 0.55, best evidence sim 1.00 (embedding). Claim type=theory, kind=theory_vs_experiment.", "paper_titles": ["Combinatorial design of ionizable lipids for lipid nanoparticle delivery of mRNA"]}, {"id": "gap_22de62aa5b96", "kind": "theory_vs_experiment", "title": "Gap: These findings suggest that endosomal escape efficiency vs These findings suggest that endosomal escape efficiency", "description": "Claim vs limitation: \"These findings suggest that endosomal escape efficiency must be improved at least 10-fold for LNP-ba\" vs \"These findings suggest that endosomal escape efficiency must be improved at least 10-fold for LNP-ba\" [Endosomal escape of lipid nanoparticles: a mechanistic investigation]", "claim_ids": ["claim_4fbf813b5387"], "evidence_ids": ["evid_ae06ef95cc13"], "paper_ids": ["paper_fa5bdf6c0470"], "magnitude": 0.55, "novelty": 0.65, "testability": 0.65, "impact": 0.65, "overall": 0.62, "domain_tags": ["lnp", "endosomal_escape"], "rationale": "Claim confidence 0.40, best evidence sim 1.00 (embedding). Claim type=mechanism, kind=theory_vs_experiment.", "paper_titles": ["Endosomal escape of lipid nanoparticles: a mechanistic investigation"]}, {"id": "gap_f9d1f51d57f7", "kind": "theory_vs_experiment", "title": "Gap: However, mechanistic understanding of how ionizable lip vs However, mechanistic understanding of how ionizable lip", "description": "Claim vs limitation: \"However, mechanistic understanding of how ionizable lipids facilitate endosomal escape is still evol\" vs \"However, mechanistic understanding of how ionizable lipids facilitate endosomal escape is still evol\" [Ionizable lipid nanoparticles for RNA delivery: design, mechanism, and applicati]", "claim_ids": ["claim_697dd41c3b8f"], "evidence_ids": ["evid_773844c79a15"], "paper_ids": ["paper_6481ce95c4b1"], "magnitude": 0.55, "novelty": 0.65, "testability": 0.65, "impact": 0.55, "overall": 0.6, "domain_tags": ["lnp", "endosomal_escape"], "rationale": "Claim confidence 0.55, best evidence sim 1.00 (embedding). Claim type=mechanism, kind=theory_vs_experiment.", "paper_titles": ["Ionizable lipid nanoparticles for RNA delivery: design, mechanism, and applications"]}, {"id": "gap_31cacf6caef6", "kind": "theory_vs_experiment", "title": "Gap: Endosomal escape of lipid nanoparticles: a mechanistic  vs Endosomal escape of lipid nanoparticles: a mechanistic ", "description": "Claim vs limitation: \"Endosomal escape of lipid nanoparticles: a mechanistic investigation  The mechanism by which lipid n\" vs \"Endosomal escape of lipid nanoparticles: a mechanistic investigation  The mechanism by which lipid n\" [Endosomal escape of lipid nanoparticles: a mechanistic investigation]", "claim_ids": ["claim_11c6d9413092"], "evidence_ids": ["evid_307901423b96"], "paper_ids": ["paper_fa5bdf6c0470"], "magnitude": 0.55, "novelty": 0.65, "testability": 0.65, "impact": 0.55, "overall": 0.6, "domain_tags": ["lnp", "endosomal_escape"], "rationale": "Claim confidence 0.55, best evidence sim 1.00 (embedding). Claim type=mechanism, kind=theory_vs_experiment.", "paper_titles": ["Endosomal escape of lipid nanoparticles: a mechanistic investigation"]}, {"id": "gap_9c8cbba9fb86", "kind": "theory_vs_experiment", "title": "Gap: We found that less than 5% of internalized mRNA reached vs We found that less than 5% of internalized mRNA reached", "description": "Claim vs limitation: \"We found that less than 5% of internalized mRNA reached the cytosol, indicating that endosomal escap\" vs \"We found that less than 5% of internalized mRNA reached the cytosol, indicating that endosomal escap\" [Endosomal escape of lipid nanoparticles: a mechanistic investigation]", "claim_ids": ["claim_99bdbbb525a8"], "evidence_ids": ["evid_1e1dc96f172b"], "paper_ids": ["paper_fa5bdf6c0470"], "magnitude": 0.55, "novelty": 0.65, "testability": 0.65, "impact": 0.55, "overall": 0.6, "domain_tags": ["endosomal_escape", "mrna"], "rationale": "Claim confidence 0.55, best evidence sim 1.00 (embedding). Claim type=mechanism, kind=theory_vs_experiment.", "paper_titles": ["Endosomal escape of lipid nanoparticles: a mechanistic investigation"]}, {"id": "gap_dcf2dbbf6dc6", "kind": "theory_vs_experiment", "title": "Gap: However, improvements in endosomal escape often correla vs However, improvements in endosomal escape often correla", "description": "Claim vs limitation: \"However, improvements in endosomal escape often correlate with increased toxicity, suggesting that p\" vs \"However, improvements in endosomal escape often correlate with increased toxicity, suggesting that p\" [The endosomal escape of lipid nanoparticles: mechanisms and strategies for impro]", "claim_ids": ["claim_45da4ae3a555"], "evidence_ids": ["evid_5cad52791402"], "paper_ids": ["paper_3b09ea60f1b3"], "magnitude": 0.55, "novelty": 0.65, "testability": 0.65, "impact": 0.55, "overall": 0.6, "domain_tags": ["endosomal_escape"], "rationale": "Claim confidence 0.55, best evidence sim 1.00 (embedding). Claim type=mechanism, kind=theory_vs_experiment.", "paper_titles": ["The endosomal escape of lipid nanoparticles: mechanisms and strategies for improvement"]}, {"id": "gap_d1ffe8549371", "kind": "other", "title": "Limitation: However, editing efficiency varied widely across tissues: 60-70% in liver, 15-20", "description": "Acknowledged limitation: \"However, editing efficiency varied widely across tissues: 60-70% in liver, 15-20% in spleen, and undetectable in lung, kidney, and muscle.\" [CRISPR-Cas9 lipid nanoparticle systems for in vivo gene editing]", "claim_ids": [], "evidence_ids": ["evid_4df29eb80e5e"], "paper_ids": ["paper_54f36a919f2b"], "magnitude": 0.95, "novelty": 0.5, "testability": 0.5, "impact": 0.45, "overall": 0.6, "domain_tags": [], "rationale": "Unmatched author-stated limitation — candidate open problem.", "paper_titles": ["CRISPR-Cas9 lipid nanoparticle systems for in vivo gene editing"]}, {"id": "gap_b261c49a6729", "kind": "other", "title": "Limitation: However, anti-PEG IgM antibodies were detected after the first dose, potentially", "description": "Acknowledged limitation: \"However, anti-PEG IgM antibodies were detected after the first dose, potentially accelerating clearance of subsequent doses.\" [Biodistribution and pharmacokinetics of lipid nanoparticle-formulated mRNA]", "claim_ids": [], "evidence_ids": ["evid_482c979dcd61"], "paper_ids": ["paper_8f84d6292278"], "magnitude": 0.95, "novelty": 0.5, "testability": 0.5, "impact": 0.45, "overall": 0.6, "domain_tags": ["pks"], "rationale": "Unmatched author-stated limitation — candidate open problem.", "paper_titles": ["Biodistribution and pharmacokinetics of lipid nanoparticle-formulated mRNA"]}, {"id": "gap_fcab343c7b9a", "kind": "other", "title": "Limitation: This tradeoff between potency and tolerability represents a fundamental challeng", "description": "Acknowledged limitation: \"This tradeoff between potency and tolerability represents a fundamental challenge in LNP design.\" [Small interfering RNA delivery via lipid nanoparticles for liver target engageme]", "claim_ids": [], "evidence_ids": ["evid_749fe9dd54d1"], "paper_ids": ["paper_a83828e7d71b"], "magnitude": 0.95, "novelty": 0.5, "testability": 0.5, "impact": 0.45, "overall": 0.6, "domain_tags": ["lnp"], "rationale": "Unmatched author-stated limitation — candidate open problem.", "paper_titles": ["Small interfering RNA delivery via lipid nanoparticles for liver target engagement"]}, {"id": "gap_c9d88d33da40", "kind": "other", "title": "Limitation: Translation to non-hepatic tissues is limited by LNP tropism.", "description": "Acknowledged limitation: \"Translation to non-hepatic tissues is limited by LNP tropism.\" [Nucleoside-modified mRNA-LNP therapeutics beyond vaccines: protein replacement a]", "claim_ids": [], "evidence_ids": ["evid_da7ba83f6c35"], "paper_ids": ["paper_b0ee8bd9e515"], "magnitude": 0.95, "novelty": 0.5, "testability": 0.5, "impact": 0.45, "overall": 0.6, "domain_tags": ["lnp"], "rationale": "Unmatched author-stated limitation — candidate open problem.", "paper_titles": ["Nucleoside-modified mRNA-LNP therapeutics beyond vaccines: protein replacement and gene editing"]}, {"id": "gap_1b0094251fb0", "kind": "other", "title": "Limitation: Furthermore, the relationship between lipidoid structure and tolerability in pul", "description": "Acknowledged limitation: \"Furthermore, the relationship between lipidoid structure and tolerability in pulmonary tissues remains poorly characterized.\" [Rapidly adaptable nanoparticle platforms for mRNA delivery to the lung]", "claim_ids": [], "evidence_ids": ["evid_0cb3f4093a10"], "paper_ids": ["paper_5c89ff1de470"], "magnitude": 0.95, "novelty": 0.5, "testability": 0.5, "impact": 0.45, "overall": 0.6, "domain_tags": ["lnp"], "rationale": "Unmatched author-stated limitation — candidate open problem.", "paper_titles": ["Rapidly adaptable nanoparticle platforms for mRNA delivery to the lung"]}, {"id": "gap_265228eb64f4", "kind": "other", "title": "Limitation: However, direct visualization of this process in living cells has been challengi", "description": "Acknowledged limitation: \"However, direct visualization of this process in living cells has been challenging.\" [The endosomal escape of lipid nanoparticles: mechanisms and strategies for impro]", "claim_ids": [], "evidence_ids": ["evid_dd13bb908a9d"], "paper_ids": ["paper_3b09ea60f1b3"], "magnitude": 0.95, "novelty": 0.5, "testability": 0.5, "impact": 0.45, "overall": 0.6, "domain_tags": [], "rationale": "Unmatched author-stated limitation — candidate open problem.", "paper_titles": ["The endosomal escape of lipid nanoparticles: mechanisms and strategies for improvement"]}, {"id": "gap_96b562008022", "kind": "theory_vs_experiment", "title": "Gap: High-performance LNPs with optimized ionizable lipid MC vs High-performance LNPs with optimized ionizable lipid MC", "description": "Claim vs limitation: \"High-performance LNPs with optimized ionizable lipid MC3 achieved the highest editing in hepatocytes\" vs \"High-performance LNPs with optimized ionizable lipid MC3 achieved the highest editing in hepatocytes\" [CRISPR-Cas9 lipid nanoparticle systems for in vivo gene editing]", "claim_ids": ["claim_cb9ab4e64527"], "evidence_ids": ["evid_cb7787ac9589"], "paper_ids": ["paper_54f36a919f2b"], "magnitude": 0.55, "novelty": 0.6, "testability": 0.65, "impact": 0.57, "overall": 0.59, "domain_tags": ["lnp", "targeting"], "rationale": "Claim confidence 0.40, best evidence sim 1.00 (embedding). Claim type=theory, kind=theory_vs_experiment.", "paper_titles": ["CRISPR-Cas9 lipid nanoparticle systems for in vivo gene editing"]}, {"id": "gap_8cd0b8b995d0", "kind": "theory_vs_experiment", "title": "Gap: Key gaps include: (1) mechanisms of LNP-induced inflamm vs Key gaps include: (1) mechanisms of LNP-induced inflamm", "description": "Claim vs limitation: \"Key gaps include: (1) mechanisms of LNP-induced inflammation remain poorly understood, (2) the contr\" vs \"Key gaps include: (1) mechanisms of LNP-induced inflammation remain poorly understood, (2) the contr\" [mRNA vaccines against COVID-19: a perspective on LNP formulation design]", "claim_ids": ["claim_2d918c935d8c"], "evidence_ids": ["evid_c42759da3e73"], "paper_ids": ["paper_b5b91c14e719"], "magnitude": 0.55, "novelty": 0.5, "testability": 0.65, "impact": 0.57, "overall": 0.57, "domain_tags": ["lnp", "delivery_efficiency"], "rationale": "Claim confidence 0.55, best evidence sim 1.00 (embedding). Claim type=theory, kind=theory_vs_experiment.", "paper_titles": ["mRNA vaccines against COVID-19: a perspective on LNP formulation design"]}, {"id": "gap_68ad96e739ff", "kind": "theory_vs_experiment", "title": "Gap: A major barrier is the rapid formation of a protein cor vs A major barrier is the rapid formation of a protein cor", "description": "Claim vs limitation: \"A major barrier is the rapid formation of a protein corona on LNPs after injection, which masks targ\" vs \"A major barrier is the rapid formation of a protein corona on LNPs after injection, which masks targ\" [Extrahepatic targeting of lipid nanoparticles in vivo]", "claim_ids": ["claim_3dca6f81e23f"], "evidence_ids": ["evid_2b9f2784acba"], "paper_ids": ["paper_a86d9c89919a"], "magnitude": 0.55, "novelty": 0.5, "testability": 0.65, "impact": 0.45, "overall": 0.54, "domain_tags": ["lnp", "corona"], "rationale": "Claim confidence 0.40, best evidence sim 1.00 (embedding). Claim type=theory, kind=theory_vs_experiment.", "paper_titles": ["Extrahepatic targeting of lipid nanoparticles in vivo"]}, {"id": "gap_293e12f3ac18", "kind": "theory_vs_experiment", "title": "Gap: However, the same SAR rules do not apply across differe vs However, the same SAR rules do not apply across differe", "description": "Claim vs limitation: \"However, the same SAR rules do not apply across different administration routes (IV vs IM vs SC).\" vs \"However, the same SAR rules do not apply across different administration routes (IV vs IM vs SC).\" [Structure-activity relationships of ionizable lipids for lipid nanoparticle deli]", "claim_ids": ["claim_92fc9fdfdbb7"], "evidence_ids": ["evid_0fe756a583c4"], "paper_ids": ["paper_93c3ce4f700f"], "magnitude": 0.55, "novelty": 0.5, "testability": 0.65, "impact": 0.45, "overall": 0.54, "domain_tags": [], "rationale": "Claim confidence 0.55, best evidence sim 1.00 (embedding). Claim type=theory, kind=theory_vs_experiment.", "paper_titles": ["Structure-activity relationships of ionizable lipids for lipid nanoparticle delivery"]}, {"id": "gap_bd33ab4dfa89", "kind": "theory_vs_experiment", "title": "Gap: Current LNPs are also less efficient at transducing pri vs Current LNPs are also less efficient at transducing pri", "description": "Claim vs limitation: \"Current LNPs are also less efficient at transducing primary cells compared to established cell lines\" vs \"Current LNPs are also less efficient at transducing primary cells compared to established cell lines\" [Nucleoside-modified mRNA-LNP therapeutics beyond vaccines: protein replacement a]", "claim_ids": ["claim_ddd854539c38"], "evidence_ids": ["evid_3221d61c9dfd"], "paper_ids": ["paper_b0ee8bd9e515"], "magnitude": 0.55, "novelty": 0.5, "testability": 0.65, "impact": 0.45, "overall": 0.54, "domain_tags": ["lnp", "corona"], "rationale": "Claim confidence 0.40, best evidence sim 1.00 (embedding). Claim type=theory, kind=theory_vs_experiment.", "paper_titles": ["Nucleoside-modified mRNA-LNP therapeutics beyond vaccines: protein replacement and gene editing"]}], "topics": [{"id": "topic_0517041645dd", "title": "Decoupling innate immune activation from LNP delivery potency", "hypothesis": "Ionizable lipid structure independently drives TLR/inflammasome activation versus endosomal escape; lipids can be optimized for high delivery with low reactogenicity.", "gap_ids": ["gap_61529d4a08b6", "gap_19145e5736f3", "gap_254c02bd1d30"], "proposed_experiments": ["Screen ionizable lipids for IL-6/IFN reporter activation in vitro", "Correlate innate activation with endosomal escape efficiency", "Validate low-inflammation high-potency candidates in mice"], "expected_readout": "≥2× potency/inflammation ratio vs SM-102 or MC3 reference LNPs.", "feasibility_notes": "Cell reporter assays are accessible; in vivo cytokine panels standard.", "impact_rationale": "Addresses 3 scored gaps in 'immunogenicity' (cluster mean overall=0.70). Success would advance therapeutically relevant nucleic acid delivery.", "priority": 0.7, "domain_tags": ["immunogenicity"]}, {"id": "topic_13f74a50b671", "title": "Ligand-displaying LNPs for extrahepatic targeting: avidity vs specificity", "hypothesis": "Multivalent display of low-affinity targeting ligands (e.g., mannose, transferrin, or anti-CD3 scFv) on LNP surfaces achieves higher tissue selectivity than high-affinity monovalent targeting, due to reduced off-target uptake by liver macrophages.", "gap_ids": ["gap_9f9225cbc5d9", "gap_80d59228631f", "gap_4f73406d9b80"], "proposed_experiments": ["Synthesize LNPs with controlled densities of selected ligands (0–100% surface coverage)", "Quantify uptake in target vs off-target cells with flow cytometry", "Test in vivo biodistribution with reporter mRNAs in xenograft or disease models"], "expected_readout": "Target-to-liver uptake ratio; ≥5× improvement over non-targeted LNPs.", "feasibility_notes": "Lipid-PEG-ligand chemistry is standard; main risk is synthesis scale-up.", "impact_rationale": "Addresses 3 scored gaps in 'targeting' (cluster mean overall=0.67). Success would advance therapeutically relevant nucleic acid delivery.", "priority": 0.67, "domain_tags": ["targeting"]}, {"id": "topic_0ce230c7a48b", "title": "Pharmacokinetic determinants of repeat-dose LNP nucleic acid delivery", "hypothesis": "PEG-lipid desorption kinetics and anti-PEG IgM jointly dominate accelerated blood clearance on redosing; tunable PEG-lipid anchors can restore multi-dose exposure.", "gap_ids": ["gap_254c02bd1d30", "gap_b261c49a6729"], "proposed_experiments": ["Vary PEG-lipid anchor length and measure circulation half-life over 3 weekly doses", "Quantify anti-PEG antibodies and correlate with clearance", "Test alternative stealth polymers (e.g., polysarcosine) as PEG replacements"], "expected_readout": "Dose 3 exposure ≥70% of dose 1 AUC for lead formulation.", "feasibility_notes": "Standard PK study design; antibody assays commercially available.", "impact_rationale": "Addresses 2 scored gaps in 'pks' (cluster mean overall=0.65). Success would advance therapeutically relevant nucleic acid delivery.", "priority": 0.65, "domain_tags": ["pks"]}, {"id": "topic_b382618236d7", "title": "Mechanistic understanding of LNP endosomal escape: fusion vs destabilization", "hypothesis": "Endosomal escape of LNPs proceeds primarily through membrane destabilization (ionizable lipid-facilitated flip-flop and bilayer disruption) rather than fusogenic mechanisms, and can be enhanced by helper lipids that lower the lamellar-to-hexagonal phase transition temperature.", "gap_ids": ["gap_c25453bc60dc", "gap_254c02bd1d30", "gap_4a4077689510"], "proposed_experiments": ["Labelled lipid mixing vs content release assays to distinguish fusion from destabilization", "Cryo-ET of LNPs in endosomal compartments at timed intervals after uptake", "Vary helper lipid ratios and correlate with endosomal escape efficiency via FRET"], "expected_readout": "Quantitative fraction of delivered cargo reaching cytosol vs lysosomal degradation.", "feasibility_notes": "Requires advanced microscopy (cryo-ET) — moderate; FRET assays are accessible.", "impact_rationale": "Addresses 3 scored gaps in 'endosomal_escape' (cluster mean overall=0.64). Success would advance therapeutically relevant nucleic acid delivery.", "priority": 0.64, "domain_tags": ["endosomal_escape"]}, {"id": "topic_706de96f1f5d", "title": "Quantitative bottleneck analysis of the LNP delivery cascade", "hypothesis": "Endosomal escape—not uptake or encapsulation—is the dominant loss term in the delivery cascade for most clinical-like LNP compositions, and 10× escape gains are necessary and sufficient for transformative dose reduction.", "gap_ids": ["gap_19145e5736f3", "gap_8cd0b8b995d0"], "proposed_experiments": ["Build a quantitative cascade map (injection→uptake→escape→translation) with barcoded mRNA", "Perturb each step independently and measure sensitivity of protein output", "Identify the step with highest elasticity for dose reduction"], "expected_readout": "Ranked elasticities per cascade step; validated 5× dose reduction via top lever.", "feasibility_notes": "Requires careful assay development; high scientific payoff.", "impact_rationale": "Addresses 2 scored gaps in 'delivery_efficiency' (cluster mean overall=0.64). Success would advance therapeutically relevant nucleic acid delivery.", "priority": 0.64, "domain_tags": ["delivery_efficiency"]}], "checklist": {"done": ["Schemas", "Ingest S2+arXiv+fixture", "Claim extractor (heuristic+LLM)", "Evidence extractor", "Gap scorer", "Topic suggester", "CLI + report", "Tests", "Modular packages", "Claim recall + LLM E2E"], "todo": ["Embedding gap alignment", "Memorization benchmark", "Corpus 50+ live", "HTML report", "Second domain", "Register BG4801"]}, "timeline": [{"date": "2026-07-01", "label": "Kickoff", "status": "done", "title": "Scope with Asst Prof Smargon", "body": "Not generic lit-search. Theory↔experiment gaps; LLM memorization safeguards; NA chemistry/delivery domain. Early progress welcome before formal August start."}, {"date": "2026-07-29", "label": "Iteration 1", "status": "current", "title": "Working vertical slice + private multi-page board", "body": "End-to-end agent shipped. LLM run 15 papers → 91 claims, 102 evidence, 47 gaps, 5 topics. Living board for async updates.", "metrics": {"papers": 15, "claims": 91, "evidence": 102, "gaps": 47, "topics": 5, "tests": "23/23"}}, {"date": "2026-08", "label": "Planned", "status": "planned", "title": "Formal start + Stage 2", "body": "BG4801 when eligible. Embeddings, memorization bench, larger corpus, optional second domain. Updates continue on this board."}, {"date": "Ongoing", "label": "Cadence", "status": "planned", "title": "Async progress updates", "body": "Each iteration adds a timeline entry and refreshed metrics so progress is reviewable without a formal meeting."}], "diagrams": {"pipeline": "flowchart TB\n  classDef src fill:#faf9f5,stroke:#c4c2b8,color:#141413\n  classDef step fill:#efe8df,stroke:#d4d2c8,color:#141413\n  classDef data fill:#ffffff,stroke:#6a9bcc,color:#141413\n  classDef out fill:#e6f0ea,stroke:#3d8b6e,color:#141413\n  subgraph S[\"Sources\"]\n    direction LR\n    S2[\"Semantic Scholar\"]\n    AX[\"arXiv\"]\n    FX[\"Offline fixture\"]\n  end\n  I[\"1 · Ingest\\ndedupe · limit · 429 → fixture\"]\n  P[(\"papers.jsonl\\ntitle + abstract\")]\n  E[\"2 · Extract\\nclaims + evidence\\nheuristic | gpt-4o-mini\"]\n  C[(\"claims.jsonl\")]\n  V[(\"evidence.jsonl\")]\n  G[\"3 · Gap score\\nJaccard + TF-cosine\\nnovelty · testability · impact\"]\n  GAP[(\"gaps.jsonl\")]\n  T[\"4 · Topics + report\\n3–5 proposals · experiments\"]\n  R[(\"topics.jsonl + latest_run.md\")]\n  S2 --> I\n  AX --> I\n  FX -.->|fallback| I\n  I --> P --> E\n  E --> C\n  E --> V\n  C --> G\n  V --> G\n  G --> GAP --> T --> R\n  class S2,AX,FX src\n  class I,E,G,T step\n  class P,C,V,GAP,R data", "extract": "flowchart TB\n  classDef box fill:#faf9f5,stroke:#d4d2c8,color:#141413\n  classDef llm fill:#e8eef5,stroke:#6a9bcc,color:#141413\n  classDef h fill:#efe8df,stroke:#d97757,color:#141413\n  classDef out fill:#e6f0ea,stroke:#3d8b6e,color:#141413\n  P[\"One paper\\ntitle + abstract only\\n(not full PDF)\"]\n  M{\"mode\"}\n  H[\"Heuristic\\nsentence split\\nregex theory/mechanism\"]\n  L[\"LLM · gpt-4o-mini\\nJSON object response\\nper-paper call\"]\n  C[\"Claim\\npaper_id + quote_span\\ntype · confidence · tags\"]\n  E[\"Evidence\\nresult · metric · limitation\\n+ quote_span\"]\n  G[\"Gap aligner\\nclaim ↔ evidence\\nmulti-axis score\"]\n  T[\"Topic proposal\\nhypothesis + experiments\"]\n  P --> M\n  M -->|heuristic| H --> C\n  M -->|llm / auto| L --> C\n  P --> E\n  C --> G\n  E --> G\n  G --> T\n  class P,M,C,E box\n  class L llm\n  class H h\n  class G,T out", "stages": "flowchart LR\n  classDef done fill:#e6f0ea,stroke:#3d8b6e,color:#141413\n  classDef now fill:#e8eef5,stroke:#6a9bcc,color:#141413\n  classDef next fill:#faf9f5,stroke:#c4c2b8,color:#141413\n  subgraph S1[\"Stage 1 shipped\"]\n    direction TB\n    a1[Schemas] --> a2[Ingest + fixture]\n    a2 --> a3[Extractors]\n    a3 --> a4[Gap scorer]\n    a4 --> a5[Topics + CLI]\n    a5 --> a6[Tests]\n  end\n  subgraph S2[\"Stage 2 current\"]\n    direction TB\n    b1[Modular + LLM E2E]\n    b2[Embeddings]\n    b3[Memorization bench]\n    b4[Corpus 50+]\n    b1 --> b2 --> b3 --> b4\n  end\n  subgraph S3[\"Next with prof\"]\n    direction TB\n    c1[Domain confirm]\n    c2[Eval rubric]\n    c3[Aug formal start]\n    c1 --> c2 --> c3\n  end\n  S1 --> S2 --> S3\n  class S1 done\n  class S2 now\n  class S3 next"}}